miR-375 maintains normal pancreatic α- and β-cell mass
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Altered growth and development of the endocrine pancreas is a frequent cause of the hyperglycemia associated with diabetes. Here we show that microRNA-375 ( miR-375 ), which is highly expressed in pancreatic islets, is required for normal glucose homeostasis. Mice lacking miR-375 ( 375KO ) are hyperglycemic, exhibit increased total pancreatic α-cell numbers, fasting and fed plasma glucagon levels, and increased gluconeogenesis and hepatic glucose output. Furthermore, pancreatic β-cell mass is decreased in 375KO mice as a result of impaired proliferation. In contrast, pancreatic islets of obese mice ( ob / ob ), a model of increased β-cell mass, exhibit increased expression of miR-375 . Genetic deletion of miR-375 from these animals ( 375 / ob ) profoundly diminished the proliferative capacity of the endocrine pancreas and resulted in a severely diabetic state. Bioinformatic analysis of transcript data from 375KO islets revealed that miR-375 regulates a cluster of genes controlling cellular growth and proliferation. These data provide evidence that miR-375 is essential for normal glucose homeostasis, α- and β-cell turnover, and adaptive β-cell expansion in response to increasing insulin demand in insulin resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“knockout of miR-375 promotes progressive hyperglycemia in mouse models due to decreased insulin content and progressive loss of β-cell mass ( 32 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [32]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Mir-375 is also involved in adaptive β-cell expansion in response to insulin resistance (518).”
From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [518]
In the citing paper
“miR-375 also regulates many genes involved in cellular proliferation, which likely underlies its effect on the maintenance of beta cell mass.”
From The Vasculature in Prediabetes (2018) · cites this paper as [139]
In the citing paper
“miR-375, an islet-specific microRNA that regulates both insulin secretion and beta cell mass.”
From The Vasculature in Prediabetes (2018) · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs
Lim, L. P., Lau, N. C., Garrett-Engele, P., Grimson, A., Schelter, J. M., Castle, J., Bartel, D. P., Linsley, P. S., & Johnson, J. M. (2005) · Nature · doi:10.1038/nature03315 · Cited by 4,755 · cited 1×
“Previous studies have established that miRNAs can negatively regulate the mRNA level of their direct targets (15), and that miRNA loss of function can result in the up-regulation of hundreds of genes (16).”
BackgroundSilencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949 · cited 2×
“Previous studies have established that miRNAs can negatively regulate the mRNA level of their direct targets (15), and that miRNA loss of function can result in the up-regulation of hundreds of genes (16).”
BackgroundMethodSelf-citationA pancreatic islet-specific microRNA regulates insulin secretion
Poy, M. N., Eliasson, L., Krutzfeldt, J., Kuwajima, S., Ma, X., MacDonald, P. E., Pfeffer, S., Tuschl, T., Rajewsky, N., Rorsman, P., et al. (2004) · Nature · doi:10.1038/nature03076 · Cited by 2,102 · cited 6×
“Northern blotting, Western blotting, and luciferase assays were performed as previously described (13).”
BackgroundMethodResultInfluentialSelf-citationControl of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA
van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J., & Olson, E. N. (2007) · Science · doi:10.1126/science.1139089 · Cited by 1,657 · cited 1×
“For instance, tissue-enriched miRNAs in the heart, such as miR-1, miR-208, and miR-133, have been shown to regulate the hypertrophic proliferative activity in response to a variety of stresses, and miR-126 affects survival after induction of a myocardial infarction (7, 12, 33).”
BackgroundThe Endothelial-Specific MicroRNA miR-126 Governs Vascular Integrity and Angiogenesis
Wang, S., Aurora, A. B., Johnson, B. A., Qi, X., McAnally, J., Hill, J. A., Richardson, J. A., Bassel-Duby, R., & Olson, E. N. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.07.002 · Cited by 1,617 · cited 1×
“For instance, tissue-enriched miRNAs in the heart, such as miR-1, miR-208, and miR-133, have been shown to regulate the hypertrophic proliferative activity in response to a variety of stresses, and miR-126 affects survival after induction of a myocardial infarction (7, 12, 33).”
BackgroundRegulation of the Germinal Center Response by MicroRNA-155
Thai, T.-H., Calado, D. P., Casola, S., Ansel, K. M., Xiao, C., Xue, Y., Murphy, A., Frendewey, D., Valenzuela, D., Kutok, J. L., et al. (2007) · Science · doi:10.1126/science.1141229 · Cited by 1,477
Dysregulation of Cardiogenesis, Cardiac Conduction, and Cell Cycle in Mice Lacking miRNA-1-2
Zhao, Y., Ransom, J. F., Li, A., Vedantham, V., von Drehle, M., Muth, A. N., Tsuchihashi, T., McManus, M. T., Schwartz, R. J., & Srivastava, D. (2007) · Cell · doi:10.1016/j.cell.2007.03.030 · Cited by 1,429
Advances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
Cited by
Items 401–500 of 767
Serum microRNAs-217 and −375 as biomarkers of acute pancreatic injury in rats
Calvano, J. E., Edwards, G., Hixson, C. J., Burr, H., Mangipudy, R. S., & Tirmenstein, M. A. (2016) · Toxicology · doi:10.1016/j.tox.2016.08.009 · Cited by 25
Involvement of MicroRNAs in Diabetes and Its Complications
Wu, B., & Miller, D. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7046-9_17 · Cited by 25
Karolina, D. S., Armugam, A., Sepramaniam, S., & Jeyaseelan, K. (2012) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.12.21 · Cited by 31
Kim, C., Lee, H., Kang, H., Shin, J. J., Tak, H., Kim, W., Gorospe, M., & Lee, E. K. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.02.017 · Cited by 26
miR-146a-5p mediates inflammation-induced β cell mitochondrial dysfunction and apoptosis
Krishnan, P., Branco, R. C. S., Weaver, S. A., Chang, G., Lee, C., Syed, F., & Evans‐Molina, C. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107827 · Cited by 25
“…noncoding RNAs that serve as global regulators of gene expression (9 – 11). miRNAs have been implicated in a variety of biological processes within the b cell, including endocrine cell speci fi cation (12), b cell development (13), insulin secretion (14), glucose regulation (15), and apoptosis (16).”
Hinton, A. C., Hunter, S. E., Reyes, G. X., Fogel, G. B., & King, C. C. (2012) · Advances in genetics · doi:10.1016/b978-0-12-394395-8.00001-3 · Cited by 25
DNA methylation of microRNA-375 in impaired glucose tolerance
Wang, X., Chang, X., Li, J., YIN, L., & Sun, K. (2014) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2014.1816 · Cited by 24
Crosstalk between microRNAs, the putative target genes and the lncRNA network in metabolic diseases
Assmann, T. S., Milagro, F. I., & Mart�nez, J. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10595 · Cited by 27
Epigenetics in β-cell adaptation and type 2 diabetes
Kim, H., & Kulkarni, R. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.10.008 · Cited by 26
Dvoretskaya, Y. D., Glanz, V. Y., Vladimirovna, G. M., Syromyatnikov, M., & Popov, V. N. (2021) · Antioxidants · doi:10.3390/antiox10111749 · Cited by 23
“At the same time, miR-375 is needed to maintain the required mass of β-cells [10].”
BackgroundMicroRNA-375, a new regulator of cadherin-7, suppresses the migration of chondrogenic progenitors
Song, J., Kim, D., Chun, C. H., & Jin, E. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.11.014 · Cited by 23
Cheng, L., Zhan, B., Luo, P., & Wang, B. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6112 · Cited by 23
Sun, Q., Yang, Q., Xu, H., Xue, J., Chen, C., Yang, X., Gao, X., & Liu, Q. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy150 · Cited by 23
“…et al., 1987), particularly in glucose homeostasis, insulin sensitivity, and function of pancreatic b-cells in the pathogenesis of diabetes (Esteves et al., 2017; Kokue et al., 1990; Lin et al., 2016; Zhuo et al., 2016). miR-375 suppresses GSIS and maintains b-cells (Poy et al., 2004, 2009).”
BackgroundShaer, A., Azarpira, N., Karimi, M. H., Soleimani, M., & Dehghan, S. (2016) · Experimental and Clinical Transplantation · doi:10.6002/ect.2014.0144 · Cited by 29
Baulina, N., Osmak, G. J., Сергеевич, К. И., Matveeva, N. A., Kukava, N. G., Shakhnovich, R. M., Кулакова, О. Г., & Favorova, O. O. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.07.129 · Cited by 24
Andl, T., Ganapathy, K., Bossan, A., & Chakrabarti, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134796 · Cited by 22
microRNA-483 Protects Pancreatic β-Cells by Targeting ALDH1A3
Wang, Z., Mohan, R., Chen, X., Matson, K., Waugh, J., Mao, Y., Zhang, S., Li, W., Tang, X., Satin, L. S., et al. (2021) · Endocrinology · doi:10.1210/endocr/bqab031 · Cited by 23
Bai, C., Ren, Q., Liu, H., Li, X., Guan, W., & Gao, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.673231 · Cited by 22
“Many reports on the differentiation of insulin-producing cells and beta-like cells from iPSCs have indicated that miR375 plays an important role in the development and insulin secretion of pancreatic beta cells (Poy et al., 2009; Enderami et al., 2017).”
BackgroundEvidence of islet CADM1-mediated immune cell interactions during human type 1 diabetes
Sona, C., Yeh, Y., Patsalos, A., Halász, L., Yan, X., Kononenko, N. L., Nagy, L., & Poy, M. N. (2022) · JCI Insight · doi:10.1172/jci.insight.153136 · Cited by 22
Self-citationKlisic, A. N., Vujacic, I. R., Munjas, J., Ninić, A., & Kotur-Stevuljevic, J. (2022) · Archives of Medical Science · doi:10.5114/aoms/146796 · Cited by 23
Exosomes as biomarkers and therapy in type 2 diabetes mellitus and associated complications
Satyadev, N., Rivera, M. I., Nikolov, N. K., & Fakoya, A. O. J. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1241096 · Cited by 22
“Of most speci fi c interest to this work is the upregulation and downregulation of several miRNAs that have been linked to the development of (and alternatively, the protection against) T2DM (Poy et al., 2004; Poy et al., 2009; Guay and Regazzi, 2013).”
Saravanan, P. B., Kanak, M. A., Chang, C., Darden, C. M., Yoshimatsu, G., Lawrence, M. C., & Naziruddin, B. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14615 · Cited by 22
Al-Muhtaresh, H. A., Salem, A. H., & Al‐Kafaji, G. (2019) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-018-9857-2 · Cited by 23
Machine learning workflows identify a microRNA signature of insulin transcription in human tissues
Wong, W. K. M., Joglekar, M. V., Saini, V., Jiang, G., Dong, C. X., Chaitarvornkit, A., Maciag, G. J., Gerace, D., Farr, R. J., Satoor, S. N., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102379 · Cited by 22
Alexandru, N., Procopciuc, A., Vîlcu, A., Comariţa, I. K., Bădilă, E., & Georgescu, A. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09664-y · Cited by 24
Li, Y., Zhang, T., Zhou, Y., Sun, Y., Cao, Y. Z., Chang, X., Zhu, Y., & Han, X. (2016) · Scientific Reports · doi:10.1038/srep36136 · Cited by 22
MicroRNA transport in cardiovascular complication of diabetes
Caporali, A., Miscianinov, V., Saif, J., & Emanueli, C. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.01.010 · Cited by 22
Hu, S., Zhang, M., Sun, F., Ren, L., He, X., Hua, J., & Peng, S. (2016) · Cell Proliferation · doi:10.1111/cpr.12263 · Cited by 21
Histone deacetylase inhibition regulates miR-449a levels in skeletal muscle cells
Poddar, S., Kesharwani, D., & Datta, M. (2016) · Epigenetics · doi:10.1080/15592294.2016.1188247 · Cited by 23
Zhang, Q., Li, J., Luo, M., Xie, G., Zeng, W., Wu, Y., Zhu, Y., Yang, X., & Guo, A. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.10.033 · Cited by 23
Anti-Cancer Drugs Reactivate Tumor Suppressor miR-375 Expression in Tongue Cancer Cells
Jung, H. M., Benarroch, Y., & Chan, E. K. L. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25039 · Cited by 20
“…insulin secretion in pancreatic cells [Poy et al., 2004]. miR-375 plays an important role in cell proliferation and maintains pancreatic b-cell mass during development as demonstrated inmice and zebrafishwith engineered genetic deletion of miR-375 [Kloosterman et al., 2007; Poy et al., 2009].”
BackgroundDusaulcy, R., Handgraaf, S., Visentin, F., Vesin, C., Philippé, J., & Gosmain, Y. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.01.004 · Cited by 20
Jin, W. L., Mulas, F., Gaertner, B., Sui, Y., Wang, J., Matta, I., Zeng, C., Vinckier, N. K., Wang, A., Nguyen-Ngoc, K.-V., et al. (2019) · iScience · doi:10.1016/j.isci.2019.10.063 · Cited by 20
“At the level of individual miRNAs, miR-375 (Kloosterman et al., 2007; Poy et al., 2009) and miR-7 (Kredo-Russo et al., 2012; Latreille et al., 2014) have been identified as regulators of beta cell differentiation and function.”
BackgroundHu, Q., Mu, J., Liu, Y., Yang, Y., Liu, Y., Pan, Y., Zhang, Y., Li, L., Liu, D., Chen, J., et al. (2022) · Diabetes · doi:10.2337/db21-0134 · Cited by 22
MicroRNAs: A new paradigm towards mechanistic insight of diseases
Nadeem, A., Ashraf, M. R., Javed, M., Hussain, T., Tariq, M. S., & Babar, M. E. (2018) · Pakistan Journal of Pharmaceutical Sciences · doi:10.36721/pjps/31/5/05.08.2018/4265/2017-2026 · Cited by 23
Expression levels of microRNA-375 in pancreatic cancer
Song, S., Zhou, J., He, S., Zhu, D., Zhang, Z., Zhao, H., Wang, Y., & Li, D. (2013) · Biomedical Reports · doi:10.3892/br.2013.88 · Cited by 22
Zhang, L., Chen, W., Dai, Y., Zhu, Z., & Liu, Q. (2016) · Experimental Biology and Medicine · doi:10.1177/1535370216638771 · Cited by 20
“Knocking out of miR-375 in mice results in hyperglycemic, and these mice also show an increase in total pancreatic alpha-cell numbers and a decrease in pancreatic beta-cell mass.(19) Abnormalities in expression of downstream genes of signaling pathways and in regulatory mechanisms occur following up- or down-regulatio…”
BackgroundMicroRNA exocytosis by large dense-core vesicle fusion
Gümürdü, A., Yildiz, R., Eren, E., Karakülah, G., Ünver, T., Genç, Ş., & Park, Y. (2017) · Scientific Reports · doi:10.1038/srep45661 · Cited by 24
Fan, K., Zebisch, A., Horny, K., Schrama, D., & Becker, J. C. (2020) · Cancers · doi:10.3390/cancers12030529 · Cited by 20
López‐Pastor, A. R., Infante‐Menéndez, J., González‐Illanes, T., González‐López, P., González‐Rodríguez, Á., García‐Monzón, C., de Céniga, M. V., Esparza, L., Gómez‐Hernández, A., & Escribano, Ó. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.049173 · Cited by 20
“Indeed, miR-149-5p was upregulated in the liver of HFD-induced hepatic insulin resistance mice (Zhao et al., 2019), and miR-375 is highly expressed in pancreatic islets involved in insulin secretion and glucose homeostasis (Poy et al., 2004, 2009).”
MicroRNA and Diabetic Bone Disease
Daamouch, S., Emini, L., Rauner, M., & Hofbauer, L. C. (2022) · Current Osteoporosis Reports · doi:10.1007/s11914-022-00731-0 · Cited by 19
Restoration of PITPNA in Type 2 diabetic human islets reverses pancreatic beta-cell dysfunction
Yeh, Y., Sona, C., Yan, X., Li, Y., Pathak, A., McDermott, M. I., Xie, Z., Liu, L., Arunagiri, A., Wang, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39978-1 · Cited by 19
Self-citationEpigenetic Manifestation of Metabolic Syndrome and Dietary Management
Chaudhary, N., Nakka, K. K., Maulik, N., & Chattopadhyay, S. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4387 · Cited by 22
Identification and Characterization of microRNAs Associated With Human β-Cell Loss in a Mouse Model
Roat, R., Hossain, M. M., Christopherson, J., Free, C., Jain, S., Guay, C., Regazzi, R., & Guo, Z. (2016) · American Journal of Transplantation · doi:10.1111/ajt.14073 · Cited by 23
MicroRNA-17-92 Regulates Beta-Cell Restoration After Streptozotocin Treatment
Wan, S., Zhang, J., Chen, X. '., Lang, J., Li, L., Chen, F., Tian, L., Meng, Y., & Yu, X. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00009 · Cited by 20
Perri, M., Caroleo, M. C., Liu, N., Gallelli, L., Sarro, G. D., Kagechika, H., & Cione, E. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.022 · Cited by 18
Ma, Y., He, T., Ge, L., Zhang, C., & Jiang, X. (2019) · BMC Medical Genomics · doi:10.1186/s12920-019-0622-4 · Cited by 19
Mendonca, A., Thandapani, P., Nagarajan, P., Venkatesh, S., & Sujatha, S. (2022) · Journal of Biosciences · doi:10.1007/s12038-022-00295-2 · Cited by 18
“miR-375, a product of the cleavage of pre-miR-375 by Dicer (Eliasson 2017), is an islet-enriched miRNA and is essential for the proper functioning of b-cells and maintaining a healthy b-cell mass (Poy et al. 2009).”
BackgroundCirculating biomarkers during progression to type 1 diabetes: A systematic review
Brenu, E., Harris, M. A., & Hamilton‐Williams, E. E. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1117076 · Cited by 18
“MiR375 is highly expressed in islet cells and regulates development of islet cell mass (alpha and beta) (43).”
BackgroundTranscriptional Mechanisms Controlling miR-375 Gene Expression in the Pancreas
Avnit-Sagi, T., Vana, T., & WALKER, M. D. (2012) · Experimental Diabetes Research · doi:10.1155/2012/891216 · Cited by 18
“miR-375 was originally reported as selectively expressed in pancreatic endocrine alpha and beta cells [8, 9], and expression was subsequently reported in the gastrointestinal tract [22] and pituitary [10].”
InfluentialWang, J., Huang, H., Wang, C., Liu, X., Hu, F., & Liu, M. (2013) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.ijom.2013.04.016 · Cited by 19
AAV8-mediated gene transfer of microRNA-132 improves beta cell function in mice fed a high-fat diet
Mulder, N. L., Havinga, R., Kluiver, J. L., Groen, A. K., & Kruit, J. K. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0287 · Cited by 18
Aberrant expression of miRNA profiles in high-fat and high-sucrose fed rats
Yerlikaya, F. H., & Öz, M. (2019) · Clinical Nutrition Experimental · doi:10.1016/j.yclnex.2019.07.001 · Cited by 19
Pantazopoulou, V. I., Georgiou, S., Kakoulidis, P., Giannakopoulou, S. N., Tseleni, S., Stravopodis, D. J., & Anastasiadou, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114007 · Cited by 20
Characterizing and classifying neuroendocrine neoplasms through microRNA sequencing and data mining
Nanayakkara, J., Tyryshkin, K., Yang, X., Wong, J. J. M., Vanderbeck, K. A., Ginter, P. S., Scognamiglio, T., Chen, Y., Panarelli, N. C., Cheung, N. V., et al. (2020) · NAR Cancer · doi:10.1093/narcan/zcaa009 · Cited by 18
The Landscape of microRNAs in βCell: Between Phenotype Maintenance and Protection
Grieco, G. E., Brusco, N., Licata, G., Fignani, D., Formichi, C., Nigi, L., Sebastiani, G., & Dotta, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020803 · Cited by 19
Patoulias, D. (2018) · Archives of Medical Science - Atherosclerotic Diseases · doi:10.5114/amsad.2018.78775 · Cited by 18
Qi, H., Li, Y., & Liu, Q. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.09.001 · Cited by 18
Shen, J., Xiang, S., Peng, M., Zhou, Z., & Wu, Z. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.02092 · Cited by 17
“Among the miRNAs, those that participated in nutrient metabolism were miR-143, which regulates adipocyte differentiation (Esau et al., 2004), and miR-375, which regulates glucagon levels and gluconeogenesis (Poy et al., 2009).”
BackgroundNovel insights regarding the role of noncoding RNAs in diabetes
Mačvanin, M., Gluvic, Z. M., Bajić, V., & Isenović, E. R. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i7.958 · Cited by 17
Hernández-Gómez, K. G., Ávila-Nava, A., González-Salazar, L. E., Noriega, L. G., Serralde-Zúñiga, A. E., Guizar-Heredia, R., Vera, I., Solis, A. L. G., Torres, N., Tovar, A. R., et al. (2023) · Metabolites · doi:10.3390/metabo13121190 · Cited by 17
“…miR-375 indicate increased expression from its synthesis in pancreatic islets in subjects with type-2 diabetes, prediabetes, and alterations in glucose or insulin [73]. miR-192 has been reported to be elevated in subjects with prediabetes and in animal models of mice with glucose intolerance [61].”
BackgroundMicroRNAs in cardiac arrhythmia: DNA sequence variation of MiR-1 and MiR-133A in long QT syndrome
Hedley, P. L., Carlsen, A. L., Christiansen, K. M., Kanters, J. K., Behr, E. R., Corfield, V. A., & Christiansen, M. (2014) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2014.905696 · Cited by 18
Insulin secretion in health and disease: nutrients dictate the pace
Regazzi, R., Rodriguez‐Trejo, A., & Jacovetti, C. (2015) · Proceedings of The Nutrition Society · doi:10.1017/s0029665115004152 · Cited by 18
Iacomino, G., Lauria, F., Russo, P., Venezia, A., Iannaccone, N., Marena, P., Ahrens, W., Henauw, S. D., Molnár, D., Eiben, G., et al. (2021) · Genes & Nutrition · doi:10.1186/s12263-021-00689-1 · Cited by 18
Gai, Y., Zhang, J., Wei, C., Cao, W. J., Cui, Y., & Cui, S. (2017) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00345.2016 · Cited by 18
Micromanaging Glucose Tolerance and Diabetes
Saliani, N., Montazersaheb, S., & Montasser-Kouhsari, S. (2017) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2017.066 · Cited by 18
“Several miRNAs are directly involved in GSIS.29 MiR375 inhibits GSIS at the late stages of exocytosis in pancreatic β-cells by targeting myotrophin.22 cAMP as a second messenger, increases insulin secretion in the presence of glucose and activates PKA, which subsequently phosphorylates and activates downstream targets…”
BackgroundMicroRNA profiling in periampullary carcinoma
Shiva, U. M. K. S., Kuruva, M. M., Sasikala, M., Talukdar, R., Venkat, R. G., Botlagunta, S., Kandagaddala, R., Siddapuram, S. P., Sekaran, A., Chemalakonda, R., et al. (2013) · Pancreatology · doi:10.1016/j.pan.2013.10.003 · Cited by 16
“Corroborating to this, miR-375 was earlier reported to be specific to pancreas and most abundant in pancreatic bcells [39].”
BackgroundYongblah, K., Alford, S. C., Ryan, B. C., Chow, R. L., & Howard, P. L. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.08.018 · Cited by 16
Micro-RNA and the Features of Metabolic Syndrome: A Narrative Review
Das, S., Mohamed, I. N., Teoh, S. L., Thevaraj, T., Ku-Ahmad-Nasir, K. N., Zawawi, A., Salim, H. H., & Zhou, D. K. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557520666200122124445 · Cited by 19
Comparative microRNA Transcriptomes in Domestic Goats Reveal Acclimatization to High Altitude
Feng, S., Ma, J., Long, K., Zhang, J., Qiu, W., Li, Y., Jin, L. G., Wang, X., Jiang, A., Liu, L., et al. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00809 · Cited by 20
“…JAK2, MTPN, and PDPK1 were predicted targets of the DE miRNA conserve-chi-miR-375-3p in this study, which is consistent with previous research (Poy et al., 2004, 2009; El Ouaamari et al., 2008); similarly, IGF1R, INSR, and IRS2 were targeted by chi-let-7a-3p (Sun et al., 2009; Zhu et al.,…”
ResultRoles of Noncoding RNAs in Islet Biology
Guay, C., Jacovetti, C., Bayazit, M. B., Brozzi, F., Rodriguez‐Trejo, A., Wu, K., & Regazzi, R. (2020) · Comprehensive physiology · doi:10.1002/cphy.c190032 · Cited by 17
Expression level of miRNAS in patients with gestational diabetes
Balcı, Ş., Görür, A., Yıldırım, D. D., Çayan, F., & Tamer, L. (2020) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2019-0157 · Cited by 16
“As a result, lacking miR-375 mice were reported to be hyperglycemic [9].”
BackgroundErener, S., Ellis, C. E., Ramzy, A., Glavas, M. M., O’Dwyer, S. M., Pereira, S., Wang, T., Pang, J., Bruin, J. E., Riedel, M. J., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100434 · Cited by 16
“miR-375 was the first reported islet-‘‘specific’’ miRNA with a role in maintaining normal a- and b-cell mass.(50,51) Although we also observed an enrichment for miR-375 in human and mouse islets, it is also expressed at high levels in other tissues, and non-pancreatic roles for this miRNA have been identified, such as…”
BackgroundExenatide reverses dysregulated microRNAs in high-fat diet-induced obese mice
Lee, I. S., Park, K. C., Yang, K., Choi, H., Jang, Y. S., Lee, J. M., & Kim, H. S. (2015) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2015.07.011 · Cited by 16
Ali, S., Nafis, S., Ponnusamy, K., Rai, E., Sharma, S., & Bamezai, R. N. K. (2016) · The Review of Diabetic Studies · doi:10.1900/rds.2016.13.17 · Cited by 17
“Deletion of this miR causes severe insulin-deficient diabetes in ob/ob mice [75, 77, 79-86].”
BackgroundBioinformatics analysis of microRNAs related to blood stasis syndrome in diabetes mellitus patients
Chen, R., Chen, M., Xiao, Y., Liang, Q., Cai, Y., Chen, L., & Fang, M. (2018) · Bioscience Reports · doi:10.1042/bsr20171208 · Cited by 17
Singh, A. P., Hung, Y.-H., Shanahan, M. T., Kanke, M., Bonfini, A., Dame, M. K., Biraud, M., Peck, B. C. E., Oyesola, O. O., Freund, J. M., et al. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.11.001 · Cited by 24
Liu, Z., Sun, J., Wang, X., & Cao, Z. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9688 · Cited by 17
He, L., Bao, T., Yang, Y., Wang, H., Gu, C., Chen, J., Zhai, T., He, X., Wu, M., Zhao, L., et al. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114786 · Cited by 19
Fine-tuning of microRNAs in Type 2 Diabetes Mellitus
Rosado, J. A., Diez-Bello, R., Salido, G. M., & Jardín, I. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867325666171205163944 · Cited by 17
Biomarkers in Islet Cell Transplantation for Type 1 Diabetes
AlRashidi, F. T., & Gillespie, K. M. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-1059-4 · Cited by 15
Duan, J., Qian, X., Li, J., Xiao, X., Lu, X., Lv, L., Huang, Q.-Y., Ding, W., Zhang, H., & Xiong, L. (2019) · International Journal of Endocrinology · doi:10.1155/2019/5219782 · Cited by 15
Ingestion of orange juice prevents hyperglycemia and increases plasma miR-375 expression
Quintanilha, B. J., Chaves, D. F. S., Brasili, E., Corrêa, T. A. F., Capetini, V. C., Ferreira, F. M., Castro, I. A., Hassimotto, N. M. A., Rogero, M. M., & Lajolo, F. M. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.12.003 · Cited by 15
Todero, J. E., Koch‐Laskowski, K., Shi, Q., Kanke, M., Hung, Y.-H., Beck, R., Stýblo, M., & Sethupathy, P. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03263-9 · Cited by 16
Marzinotto, I., Pellegrini, S., Brigatti, C., Nano, R., Melzi, R., Mercalli, A., Liberati, D., Sordi, V., Ferrari, M., Falconi, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13622-7 · Cited by 15
Wang, S.-H., Zhao, Y. F., Wang, C.-C., Chu, F., Miao, L., Zhang, L., Zhuo, L., & Chen, X. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108177 · Cited by 14
Clinical research progress on β-cell dysfunction in T2DM development in the Chinese population
Chen, Y., Jiang, Q., Xing, X., Yuan, T., & Li, P. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09914-9 · Cited by 16
miRNAs: Nanomachines That Micromanage the Pathophysiology of Diabetes Mellitus
Sharma, S., Mathew, A. B., & Chugh, J. (2017) · Advances in clinical chemistry · doi:10.1016/bs.acc.2017.06.003 · Cited by 15
Lesch, A., Backes, T. M., Langfermann, D. S., Rößler, O. G., Laschke, M. W., & Thiel, G. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104983 · Cited by 17
Ayan, E. B., & DeMirci, H. (2022) · Current Diabetes Reviews · doi:10.2174/1573399819666220610150342 · Cited by 15
Doubly thiazole orange-labeled cytidine for functional expansion of a hybridization-sensitive probe
Ikeda, S., Yuki, M., Yanagisawa, H., & Okamoto, A. (2009) · Tetrahedron Letters · doi:10.1016/j.tetlet.2009.10.037 · Cited by 14
Novel Pancreatic Endocrine Maturation Pathways Identified by Genomic Profiling and Causal Reasoning
Gutteridge, A., Rukstalis, J. M., Ziemek, D., Tié, M., Ji, L., Ramos-Zayas, R., Nardone, N. A., Norquay, L., Brenner, M. B., Tang, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056024 · Cited by 14
Epigenetic Regulation of Pancreatic Islets
Haumaître, C. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0403-y · Cited by 14
Roles of Regulatory RNAs in Nutritional Control
McNeill, E. M., & Hirschi, K. D. (2020) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-122319-035633 · Cited by 15
Oda, S., & Yokoi, T. (2021) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2020.11.007 · Cited by 15
Cell Based Assays: the Cell Cycle, Cell Proliferation and Cell Death
Cobb, L. J. (2013) · Materials and Methods · doi:10.13070/mm.en.3.172 · Cited by 21
Beyond the Protein-Coding Sequence: Noncoding RNAs in the Pathogenesis of Type 2 Diabetes
DiStefano, J. K. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.260 · Cited by 17
“and hepatic glucose output, and higher levels of fasting and fed glucagon [49].”
BackgroundZhang, T., Ji, C., & Shi, R. (2019) · Europe PMC (PubMed Central) · Cited by 19
Dietary modulation of microRNAs in insulin resistance and type 2 diabetes
Capetini, V. C., Quintanilha, B. J., Garcia, B. R. E. V., & Rogero, M. M. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109714 · Cited by 15
Ghaedi, H., Bastami, M., Jahani, M. M., Alipoor, B., Tabasinezhad, M., Ghaderi, O., Nariman‐Saleh‐Fam, Z., Mirfakhraie, R., Movafagh, A., Omrani, M. D., et al. (2016) · Biochemical Genetics · doi:10.1007/s10528-016-9713-5 · Cited by 13
“In fact, the role of miR-375 is to establish a normal pancreatic cell mass through the targeting of a group of genes that regulate the cellular growth and proliferation in the developing pancreas (Poy et al. 2009).”
Background
Metadata
- Authors
- Poy, M. N., Hausser, J., Trajkovski, M., Braun, M., Collins, S., Rorsman, P., Zavolan, M., & Stoffel, M.
- Affiliations
- ETH Zurich (CH)
- SIB Swiss Institute of Bioinformatics (CH)
- Churchill Hospital (GB)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2009-04-07
- Volume
- 106
- Issue
- 14
- Pages
- 5813-5818
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2656556
- OpenAlex
- W2073803015
- Cited by
- 740
- References
- 36
- Citations by year
- 2026: 16 · 2025: 17 · 2024: 23 · 2023: 26 · 2022: 35 · 2021: 38 · 2020: 39 · 2019: 52 · 2018: 47 · 2017: 58 · 2016: 59 · 2015: 67 · 2014: 72 · 2013: 60 · 2012: 53
- FWCI
- 43.94
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Funders
- Wellcome Trust
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (114001, 3100A0)
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- miR-375, microRNA, alpha cells, pancreatic beta cells, beta-cell mass, glucose homeostasis, hyperglycemia, glucagon, gluconeogenesis, hepatic glucose production, beta-cell proliferation, islet development, obesity, insulin resistance, diabetes mellitus, cell proliferation
- MeSH terms
- Animals, Blood Glucose, Homeostasis, Insulin, Islets of Langerhans, Mice, Obese, Mice, Knockout, MicroRNAs, Cell Proliferation, Glucagon-Secreting Cells, Insulin-Secreting Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.